BRAF and non-small cell lung carcinoma: To explore the coexistence of PIK3CA and other oncogene mutations in non-small cell lung cancer, testing for EGFR, KRAS, HER2, BRAF, AKT1 gene mutations and ALK rearrangement was also arranged.